Brief: Inventiva Says Co's Partner Sino Biopharm Received IND Approval To Initiate Clinical Trial With Lanifibranor In China

Inventiva SA

25/05/2023 21:03

May 25 (Reuters) - Inventiva Sa  IVAA.PA :
    * INVENTIVA ANNOUNCES THAT ITS PARTNER SINO BIOPHARM
RECEIVED IND
APPROVAL FROM THE NMPA TO INITIATE CLINICAL TRIAL WITH
LANIFIBRANOR IN CHINA
    * IS ELIGIBLE TO FIRST OF 2 SHORT TERM MILESTONES AMOUNTING
TO A
TOTAL OF $5 MILLION, UNDER LICENSE AND COLLABORATION AGREEMENT
WITH CTTQ
    * IN PARALLEL, SINO BIOPHARM WILL CONDUCT A PHASE I CLINICAL
PHARMACOLOGY STUDY

Source text for Eikon:  ID:nGNE6lbW3z 
Further company coverage:  IVAA.PA 

 ((Reuters.Briefs@thomsonreuters.com;;))